Qurexa Logo
Qurexa

Trust. Care. Deliver.

Back to Blog & Insights
Technology

Scientists have found what may be CRISPR's ancestor - and it came from viruses

Qurexa Editorial Team20 September 20265 min read 0 0
Scientists have found what may be CRISPR's ancestor - and it came from viruses

What happened

CRISPR is the gene-editing tool that has changed biology over the past decade. It lets scientists find one exact spot in a strand of DNA and change it. It came out of a defence system that bacteria use to fight off viruses. But where did that defence system itself come from? On 18 September 2026, two studies published in the journal Science put forward an answer. The lead author was Peter H. Yoon. The team found a system they call VIPR, short for Viral Interference Programmable Repeat. It sits in the genomes of bacteria and viruses, and it works in a way that looks like an earlier, simpler version of CRISPR. The twist is where it came from. VIPR appears to have started in viruses themselves. The researchers suggest that bacteria later borrowed it and turned it into a defence system against the very viruses it came from. The two papers carry the reference numbers 10.1126/science.aei0498 and 10.1126/science.aei3472.

Why this matters

Two reasons: one about the past, one about the future. The past one is a good story. It suggests bacteria did not invent their anti-virus weapon from scratch. They took a tool the viruses were already using and turned it around. In evolution, that kind of borrowing happens more often than people expect. The future one is more practical. Every new RNA-guided system gives scientists another option in the toolbox. Today's CRISPR tools are good, but not perfect. Some are bulky, which makes them hard to fit inside the tiny delivery vehicles used to get them into human cells. Some cut in places they were not meant to. Different proteins have different quirks. The researchers describe VIPR as one of the most minimal and potentially versatile platforms found so far for recognising DNA using an RNA guide. Small and simple is genuinely useful in this field.

What the evidence actually says

The team did more than look at genetic sequences on a computer. They tested the system. In E. coli, a bacterium used in labs all over the world, they reprogrammed VIPR to silence chosen genes. It worked. They also used it to block a virus from infecting the bacteria. That worked too. The way VIPR finds its target is unusual. Modern CRISPR systems form what is called an R-loop: the guide RNA slots into the DNA and pushes one strand aside. VIPR does something different. It uses what the researchers call protein-driven triplex formation - a three-stranded DNA structure - to prise the DNA open. It also uses an odd targeting code that the team describe as "skip-one". It is worth being clear about what this is and is not. This is early-stage laboratory science in bacteria. Nobody has used VIPR to edit a human cell, and the idea that it is CRISPR's ancestor is a proposal based on how the pieces fit together, not a proven family tree. The evolutionary claim in particular will be argued over. That is normal, and it is how this should work. But the laboratory demonstrations are concrete: the system was reprogrammed, and it did what it was told to do.

Practical advice

Nothing here changes any treatment today, and it should not change any decision you make about your health. If you want to follow this field sensibly, a few habits help. Watch for the gap between a laboratory result and a treatment. Work in bacteria is roughly a decade away from anything that might reach a patient, and most such work never gets there. That is not a criticism of the science. It is just how research works. Be wary of headlines that say a discovery will "cure" something. The papers themselves almost never say that. If you or someone in your family has a genetic condition and you are curious about gene-editing treatments, the useful questions are about trials that are recruiting now, not about early lab findings. Your specialist team is the right place to ask, and in the UK the Be Part of Research service lists studies looking for volunteers. And if you simply enjoy this kind of thing, both Science papers are real and referenced below. The abstracts are readable even if the methods are not.

What to know

Researchers have described VIPR, an RNA-guided system found in viruses and bacteria that appears to be an early relative of CRISPR. It works differently from modern CRISPR, using a three-stranded DNA structure rather than the usual R-loop, and it is unusually small and simple. In tests, the team reprogrammed it to switch off genes in E. coli and to block a virus from infecting those bacteria. The headline idea - that bacteria borrowed their anti-virus weapon from viruses - is a proposal that other scientists will now test. The laboratory results stand on their own, and they suggest another tool may be joining the gene-editing toolbox. Sources: Science, two studies on the VIPR system, 18 September 2026, DOI 10.1126/science.aei0498 and DOI 10.1126/science.aei3472, https://doi.org/10.1126/science.aei0498 | Phys.org, "Discovery of CRISPR's long lost ancestor may expand gene-editing toolkit", 18 September 2026, https://phys.org/news/2026-09-discovery-crispr-lost-ancestor-gene.html This article is for general information. It does not describe a treatment, and it does not replace advice from a doctor, pharmacist or other qualified healthcare professional.

#CRISPR#gene editing#viruses#bacteria#evolution#Science journal

Related articles